CONAVI MEDICAL CORP (CNVI.CA) Stock Income Statement
Canada - TSX-V:CNVI - CA2059531020 - Common Stock
0.61 CAD
+0.01 (+1.67%)
| TTM (2025-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.76M | 24.24M | 0.00 | 27.63M | 20.00M | |||
| Operating Expenses | 19.70M | 11.94M | 61.56M | 70.23M | 15.80M | |||
| Research and Development | 11.68M | 441.40K | 45.38M | 52.19M | 7.94M | |||
| Selling, General, and Administrative Expenses | 7.17M | 11.24M | 14.99M | 17.09M | 7.63M | |||
| Operating Income | -12.40M | 12.30M | -61.56M | -42.61M | 4.20M | |||
| Interest Income/Expense | -11.52M | 636.60K | 6.17M | 21.42M | -29.04M | |||
| Other Income/Expense | N/A | 144.40K | 0.00 | 831.90K | -1.82M | |||
| Non Recurring Items | -4.87M | -3.82M | -3.18M | 0.00 | 2.47M | |||
| Income Before Taxes | -16.22M | 9.59M | -58.57M | -20.35M | -24.18M | |||
| Income Tax | N/A | 33.00K | -77.00K | 77.00K | N/A | |||
| Net Income | -16.22M | 9.56M | -58.50M | -20.43M | -24.18M | |||
| EBITDA | N/A | 12.56M | -60.38M | -41.65M | 4.44M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.85 | 0.08 | -0.52 | -0.19 | -0.36 | |||
| Statistics | ||||||||
| Profit Margin | -185.28% | 39.43% | N/A | -73.95% | -120.90% | |||
| Operating Profit Margin | -141.66% | 50.75% | N/A | -154.22% | 21.00% | |||
All data in CAD